Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitus

Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitus - Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053067

Enrollment

Registered

2023-12-12

Start date

2020-09-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Semaglutide injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Patients who do not agree to participate in the study Patients judged by the attending physician that there is no indication for Semaglutide injection

Design outcomes

Secondary

Measure	Time frame
Changes in eating behavior measured by the eating behavior questionnaire and the assessment of the efficacy of the drug before and after six months of semaglutide injection.	—

Primary

Measure	Time frame
Changes of Satisfaction score measured in the DTSQ by seven possible responses (varying from 0; very dissatisfied, to 6; very satisfied, varying by integers), both previous and six months subsequent to Semaglutide injection.	—

Countries

Japan

Contacts

Public ContactRyoichi Ishibashi

Kimitsu Chuo Hospital Department of Medicine, Division of Diabetes, Endocrinology and Metabolism

ishibashi-cib@umin.net+81-438-36-1071

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026